Evidence map›Paper›PMID 24912151›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Loss of the death receptor CD95 (Fas) expression by dendritic cells protects from a chronic viral infection.

Vineeth Varanasi, Aly Azeem Khan, Alexander V Chervonsky

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. The Effects of Dendritic Cell Hypersensitivity on Persistent Viral Infection.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Vineeth VaranasiDepartment of Pathology and Committee on Immunology, and.
Aly Azeem KhanInstitute for Genomics and Systems Biology and Department of Human Genetics, The University of Chicago, Chicago, IL 60637.
Alexander V ChervonskyDepartment of Pathology and Committee on Immunology, and achervon@bsd.uchicago.edu.
University of Chicago · US

Funding

Fas in host defense and autoimmune diseasesR01AI072627 · NIAID · UNIVERSITY OF CHICAGO · PI CHERVONSKY, ALEXANDER V · 2007 to 2011
$1.9M
NIAID NIH HHS R01 AI072627NIAID NIH HHS R01AI072627
6 · The paper itself

Abstract

Chronic viral infections incapacitate adaptive immune responses by "exhausting" virus-specific T cells, inducing their deletion and reducing productive T-cell memory. Viral infection rapidly induces death receptor CD95 (Fas) expression by dendritic cells (DCs), making them susceptible to elimination by the immune response. Lymphocytic choriomeningitis virus (LCMV) clone 13, which normally establishes a chronic infection, is rapidly cleared in C57Black6/J mice with conditional deletion of Fas in DCs. The immune response to LCMV is characterized by an extended survival of virus-specific effector T cells. Moreover, transfer of Fas-negative DCs from noninfected mice to preinfected animals results in either complete clearance of the virus or a significant reduction of viral titers. Thus, DC-specific Fas expression plays a role in regulation of antiviral responses and suggests a strategy for stimulation of T cells in chronically infected animals and humans to achieve the clearance of persistent viruses.

Indexed as

AnimalsCell LineCell SurvivalChlorocebus aethiopsChronic DiseaseDendritic Cellsfas ReceptorGene DeletionHost-Pathogen InteractionsHumansLymphocyte ActivationLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, Inbred C57BLMice, Transgenicfas Receptor

Identifiers

PMID24912151
PMCPMC4060656
OpenAlexW2136286975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.